Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/24/2022 | $24.00 → $10.00 | Buy | B. Riley Securities |
| 11/9/2021 | $24.00 | Buy | B. Riley Securities |
| 11/9/2021 | $26.00 | Outperform | Robert W. Baird |
| 11/9/2021 | Outperform | William Blair | |
| 11/9/2021 | $30.00 | Outperform | Evercore ISI Group |
| 11/9/2021 | $26.00 | Outperform | Baird |
4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
4 - MiNK Therapeutics, Inc. (0001840229) (Issuer)
B. Riley Securities reiterated coverage of MiNK Therapeutics with a rating of Buy and set a new price target of $10.00 from $24.00 previously
B. Riley Securities initiated coverage of MiNK Therapeutics with a rating of Buy and set a new price target of $24.00
Robert W. Baird initiated coverage of MiNK Therapeutics with a rating of Outperform and set a new price target of $26.00